Through various downstream pathways, EGFR is known to regulate lipid metabolism in the liver [32,41] and its dysregulation is found to be associated with lipid accumulation and NAFLD. The gene discussed is EGFR; the disease is metabolic dysfunction-associated steatotic liver disease.